Evidence map›Paper›PMID 34378986›Full record

ArticlemSphere2021

Direct Antibiotic Activity of Bacillibactin Broadens the Biocontrol Range of Bacillus amyloliquefaciens MBI600.

Anastasia Dimopoulou, Ioannis Theologidis, Dimitra Benaki, Marilena Koukounia, Amalia Zervakou, Aliki Tzima, George Diallinas, Dimitris G Hatzinikolaou, Nicholas Skandalis

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
21.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 157 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. FeBiofilm · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Draft Genome Sequence ofMicroorganisms · 2026
    Article
  11. Review
  12. Article
  13. Lipopeptides fromBiotech (Basel (Switzerland)) · 2026
    Article
  14. Article
  15. Article
  16. Genomic insights and evaluation ofFrontiers in cellular and infection microbiology · 2026
    Article
  17. Review
  18. Article
  19. Article
  20. Proposal ofInternational journal of molecular sciences · 2025
    Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Anastasia DimopoulouInstitute of Molecular Biology and Biotechnology, FORTH, Heraklion, Greece.
Ioannis TheologidisInstitute of Molecular Biology and Biotechnology, FORTH, Heraklion, Greece.
Dimitra BenakiDepartment of Pharmacy, National and Kapodistrian University of Athensgrid.5216.0, Athens, Greece.
Marilena KoukouniaInstitute of Molecular Biology and Biotechnology, FORTH, Heraklion, Greece.
Amalia ZervakouDepartment of Biology, Sector of Botany, National and Kapodistrian University of Athensgrid.5216.0, Athens, Greece.
Aliki TzimaLaboratory of Plant Pathology, Agricultural University of Athens, Athens, Greece.
George DiallinasInstitute of Molecular Biology and Biotechnology, FORTH, Heraklion, Greece.
Dimitris G HatzinikolaouDepartment of Biology, Sector of Botany, National and Kapodistrian University of Athensgrid.5216.0, Athens, Greece.
Nicholas SkandalisDepartment of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
National and Kapodistrian University of Athens · GRFORTH Institute of Molecular Biology and Biotechnology · GRAgricultural University of Athens · GRUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacillus amyloliquefaciens is considered the most successful biological control agent due to its ability to colonize the plant rhizosphere and phyllosphere where it outgrows plant pathogens by competition, antibiosis, and inducing plant defense. Its antimicrobial function is thought to depend on a diverse spectrum of secondary metabolites, including peptides, cyclic lipopeptides, and polyketides, which have been shown to target mostly fungal pathogens. In this study, we isolated and characterized the catecholate siderophore bacillibactin by

Indexed as

Anti-Bacterial AgentsAntibiosisAntifungal AgentsBacillus amyloliquefaciensBiological Control AgentsFungiIronOligopeptidesPlant DiseasesPseudomonas syringaeSiderophoresAnti-Bacterial AgentsAntifungal AgentsbacillibactinBiological Control AgentsIronOligopeptidesSiderophoresantibioticsBacillus amyloliquefaciensbactericidesiron starvationplant-pathogenic bacteriaplant pathogenssiderophores

Identifiers

PMID34378986
PMCPMC8386435
OpenAlexW3190738640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.